**Fabio Medas 1,\* , Gian Luigi Canu <sup>1</sup> , Federico Cappellacci <sup>1</sup> , Giacomo Anedda <sup>1</sup> , Giovanni Conzo 2, Enrico Erdas <sup>1</sup> and Pietro Giorgio Calò <sup>1</sup>**


Received: 19 May 2020; Accepted: 20 June 2020; Published: 23 June 2020

**Abstract:** The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the secondary goal was to estimate the incidence of postoperative complications in patients who underwent pCLND and to evaluate the prognostic value of occult node metastases. In this retrospective study, we included patients with preoperative diagnosis of DTC and clinically uninvolved lymph nodes (cN0). The patients were divided into two groups, depending on the surgical approach: total thyroidectomy alone (TT group) or total thyroidectomy and pCLND (pCLND group). Three hundred and ninety-nine patients were included in this study, 320 (80.2%) in the TT group and 79 (19.8%) in the pCLND group. There were no significant differences in morbidity among the two groups. Histopathological evaluation demonstrated a similar distribution of aggressive features, especially regarding multicentricity, extrathyroidal extension, and angioinvasivity between the two groups. Occult lymph node metastases were found in 20 (25.3%) patients in the pCLND group. Prophylactic CLND was effective in improving disease-free survival in patients with intermediate and high risk of disease recurrence (*p* = 0.0392); occult lymph node metastases resulted as a significant negative prognostic factor (*p* < 0.001).

**Keywords:** thyroid carcinoma; prophylactic central lymph node dissection; lymph node metastases
